Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) Shares Outstanding (Weighted Average) (2024 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $22.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 150.38% to $22.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.9 million through Dec 2025, up 150.38% year-over-year, with the annual reading at $22.9 million for FY2025, 150.38% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $22.9 million in Q4 2025 for Guardian Pharmacy Services, down from $43.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $52.8 million in Q3 2024 to a low of $9.2 million in Q4 2024.